Complete Molecular and Hematologic Response in Adult Patients with Relapsed/Refractory (R/R) Philadelphia Chromosome-Positive B-Precursor Acute Lymphoblastic Leukemia (ALL) Following Treatment with Blinatumomab: Results from a Phase 2 Single-Arm, Multicenter Study (ALCANTARA)
Giovanni Martinelli(University of Bologna), Anthony S. Stein(University of Hohenheim), Lulu Ren Sterling(Esperion Therapeutics (United States)), Nicola Goekbuget(Goethe University Frankfurt), Patrice Chevallier(Hotel Dieu Hospital), Oliver G. Ottmann(Cardiff University), Adele K. Fielding(New York Blood Center), Hervé Dombret(University of London Institute in Paris), Max S. Topp(Universitätsklinikum Würzburg), Jonathan Benjamin(Amgen (United States))
Cited by 49
Related Papers
Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel
|Blood|2016|5.9k
Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN
|Blood|2022|3.1k